Author:
Zhao Ting,Li Hong-jian,Zhang Hui-lan,Yu Jing,Feng Jie,Wang Ting-ting,Sun Yan,Yu Lu-hai
Funder
The scientific Research Fund of Pharmaceutical Society of Xinjiang Uygur Autonomous Region
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference25 articles.
1. Sang T, Xiang T, Zhu SN, et al. Treatment-related costs of childhood epilepsy in Mainland China: a preliminary study in a tertiary pediatric epilepsy center. J Child Neurl. 2019;34(2):68–73.
2. Höfler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia. 2013;54(3):393–404.
3. Zhao T, Li HJ, Ma L, Feng J, et al. Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur China. Epilepsy Behav. 2021;117: 107814.
4. Chimakurthy AK, Ramsay RE, Sabharwal V, Menon U. Safety, tolerability, and pharmacokinetics of weight-based IV loading dose of lacosamide in the ICU. Epilepsy Behav. 2020;114(Pt A): 107449.
5. Biton V, Gil-Nagel A, Isojärvi J, et al. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials. Epilepsy Behav. 2015;52(Pt A):119–27.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献